A citation-based method for searching scientific literature

Laetitia Collet, Julien Péron, Frédérique Penault-Llorca, Pascal Pujol, Jonathan Lopez, Gilles Freyer, Benoît You. Cancers (Basel) 2022
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


5-Azacitidine Exerts Prolonged Pro-Apoptotic Effects and Overcomes Cisplatin-Resistance in Non-Seminomatous Germ Cell Tumor Cells.
Christoph Oing, Izudin Verem, Wael Y Mansour, Carsten Bokemeyer, Sergey Dyshlovoy, Friedemann Honecker. Int J Mol Sci 2018
22
50

Eukaryotic cytosine methyltransferases.
Mary Grace Goll, Timothy H Bestor. Annu Rev Biochem 2005
50

5-Azacitidine Induces NOXA to Prime AML Cells for Venetoclax-Mediated Apoptosis.
Sha Jin, Dan Cojocari, Julie J Purkal, Relja Popovic, Nari N Talaty, Yu Xiao, Larry R Solomon, Erwin R Boghaert, Joel D Leverson, Darren C Phillips. Clin Cancer Res 2020
54
50

Dynamics of DNA demethylation.
Tal Nawy. Nat Methods 2013
5
50

The Enigmatic Function of PARP1: From PARylation Activity to PAR Readers.
Tatiana Kamaletdinova, Zahra Fanaei-Kahrani, Zhao-Qi Wang. Cells 2019
53
50

Secondary mutations in BRCA2 associated with clinical resistance to a PARP inhibitor.
Louise J Barber, Shahneen Sandhu, Lina Chen, James Campbell, Iwanka Kozarewa, Kerry Fenwick, Ioannis Assiotis, Daniel Nava Rodrigues, Jorge S Reis Filho, Victor Moreno,[...]. J Pathol 2013
231
50

DNA Methylation Reprogramming during Mammalian Development.
Yang Zeng, Taiping Chen. Genes (Basel) 2019
129
50

Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models.
Verona Buocikova, Eleonora Marta Longhin, Eleftherios Pilalis, Chara Mastrokalou, Svetlana Miklikova, Marina Cihova, Alexandra Poturnayova, Katarina Mackova, Andrea Babelova, Lenka Trnkova,[...]. Biomed Pharmacother 2022
8
50

The transcriptional landscape and mutational profile of lung adenocarcinoma.
Jeong-Sun Seo, Young Seok Ju, Won-Chul Lee, Jong-Yeon Shin, June Koo Lee, Thomas Bleazard, Junho Lee, Yoo Jin Jung, Jung-Oh Kim, Jung-Young Shin,[...]. Genome Res 2012
416
50

Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements.
Gangning Liang, Matilda F Chan, Yoshitaka Tomigahara, Yvonne C Tsai, Felicidad A Gonzales, En Li, Peter W Laird, Peter A Jones. Mol Cell Biol 2002
404
50

Kinase-mediated changes in nucleosome conformation trigger chromatin decondensation via poly(ADP-ribosyl)ation.
Colin J Thomas, Elena Kotova, Mark Andrake, Jared Adolf-Bryfogle, Robert Glaser, Catherine Regnard, Alexei V Tulin. Mol Cell 2014
32
50

Research Advances in the Role of the Poly ADP Ribose Polymerase Family in Cancer.
Huanhuan Sha, Yujie Gan, Renrui Zou, Jianzhong Wu, Jifeng Feng. Front Oncol 2021
2
50


Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: TALAPRO-2 phase III study design.
Neeraj Agarwal, Arun Azad, Neal D Shore, Joan Carles, Andre P Fay, Curtis Dunshee, Lawrence Ivan Karsh, Maria Luisa Paccagnella, Nicola Di Santo, Mohamed Elmeliegy,[...]. Future Oncol 2022
4
50


DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load.
Hyunchul Jung, Hong Sook Kim, Jeong Yeon Kim, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Manel Esteller, Se-Hoon Lee, Jung Kyoon Choi. Nat Commun 2019
154
50

Hydralazine and Enzalutamide: Synergistic Partners against Prostate Cancer.
Nair Lopes, Mariana Brütt Pacheco, Diana Soares-Fernandes, Margareta P Correia, Vânia Camilo, Rui Henrique, Carmen Jerónimo. Biomedicines 2021
1
100

TET family dioxygenases and DNA demethylation in stem cells and cancers.
Jungeun An, Anjana Rao, Myunggon Ko. Exp Mol Med 2017
88
50

An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA Mutations.
Nicholas Pulliam, Fang Fang, Ali R Ozes, Jessica Tang, Adeoluwa Adewuyi, Harold Keer, John Lyons, Stephen B Baylin, Daniela Matei, Harikrishna Nakshatri,[...]. Clin Cancer Res 2018
68
50

PARP1 orchestrates epigenetic events setting up chromatin domains.
Fabio Ciccarone, Michele Zampieri, Paola Caiafa. Semin Cell Dev Biol 2017
66
50

Dnmt3L antagonizes DNA methylation at bivalent promoters and favors DNA methylation at gene bodies in ESCs.
Francesco Neri, Anna Krepelova, Danny Incarnato, Mara Maldotti, Caterina Parlato, Federico Galvagni, Filomena Matarese, Hendrik G Stunnenberg, Salvatore Oliviero. Cell 2013
121
50

Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
J G Herman, F Latif, Y Weng, M I Lerman, B Zbar, S Liu, D Samid, D S Duan, J R Gnarra, W M Linehan. Proc Natl Acad Sci U S A 1994
50

Histone-dependent PARP-1 inhibitors: A novel therapeutic modality for the treatment of prostate and renal cancers.
Peter Makhov, Robert G Uzzo, Alexei V Tulin, Vladimir M Kolenko. Urol Oncol 2021
6
50


Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression.
Jun Gao, Lihua Wang, Jinkang Xu, Jianming Zheng, Xiaohua Man, Hongyu Wu, Jin Jin, Kaixuan Wang, Huasheng Xiao, Shude Li,[...]. J Exp Clin Cancer Res 2013
49
50


Poly(ADP-ribose) binds to specific domains of p53 and alters its DNA binding functions.
M Malanga, J M Pleschke, H E Kleczkowska, F R Althaus. J Biol Chem 1998
187
50

Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies.
Antonella Padella, Andrea Ghelli Luserna Di Rorà, Giovanni Marconi, Martina Ghetti, Giovanni Martinelli, Giorgia Simonetti. J Hematol Oncol 2022
8
50


5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes.
W M Rideout, G A Coetzee, A F Olumi, P A Jones. Science 1990
566
50

TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair.
Yimei Feng, Xiaoping Li, Kaniel Cassady, Zhongmin Zou, Xi Zhang. Front Oncol 2019
54
50

Delivery of 5-azacytidine to human cancer cells by elaidic acid esterification increases therapeutic drug efficacy.
Bodo Brueckner, Maria Rius, Maria Rivera Markelova, Iduna Fichtner, Petter-Arnt Hals, Marit Liland Sandvold, Frank Lyko. Mol Cancer Ther 2010
61
50


Epigenetic Enzyme Mutations: Role in Tumorigenesis and Molecular Inhibitors.
Mei Han, Lina Jia, Wencai Lv, Lihui Wang, Wei Cui. Front Oncol 2019
38
50

Poly(ADP)-Ribosylation Inhibition: A Promising Approach for Clear Cell Renal Cell Carcinoma Therapy.
Yaroslava Karpova, Danping Guo, Peter Makhov, Adam M Haines, Dmitriy A Markov, Vladimir Kolenko, Alexei V Tulin. Cancers (Basel) 2021
6
50

Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicing.
Anna Dolnik, Julia C Engelmann, Maren Scharfenberger-Schmeer, Julian Mauch, Sabine Kelkenberg-Schade, Berit Haldemann, Tamara Fries, Jan Krönke, Michael W M Kühn, Peter Paschka,[...]. Blood 2012
110
50

Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.
Elizaveta E Alemasova, Olga I Lavrik. Nucleic Acids Res 2019
163
50

PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling.
Lotte van Beek, Éilís McClay, Saleha Patel, Marianne Schimpl, Laura Spagnolo, Taiana Maia de Oliveira. Int J Mol Sci 2021
18
50

PARP1: Structural insights and pharmacological targets for inhibition.
Jacob O Spiegel, Bennett Van Houten, Jacob D Durrant. DNA Repair (Amst) 2021
8
50

Zebularine partially reverses GST methylation in prostate cancer cells and restores sensitivity to the DNA minor groove binder brostallicin.
Maria Antonietta Sabatino, Cristina Geroni, Monica Ganzinelli, Roberta Ceruti, Massimo Broggini. Epigenetics 2013
16
50

ADP-ribosyltransferases Parp1 and Parp7 safeguard pluripotency of ES cells.
Stephen J Roper, Stephanie Chrysanthou, Claire E Senner, Arnold Sienerth, Stefano Gnan, Alexander Murray, Mitsuko Masutani, Paulina Latos, Myriam Hemberger. Nucleic Acids Res 2014
57
50

Tet3 Reads 5-Carboxylcytosine through Its CXXC Domain and Is a Potential Guardian against Neurodegeneration.
Seung-Gi Jin, Zhi-Min Zhang, Thomas L Dunwell, Matthew R Harter, Xiwei Wu, Jennifer Johnson, Zheng Li, Jiancheng Liu, Piroska E Szabó, Qiang Lu,[...]. Cell Rep 2016
79
50

DNA Hypomethylation Contributes to Genomic Instability and Intestinal Cancer Initiation.
Karyn L Sheaffer, Ellen N Elliott, Klaus H Kaestner. Cancer Prev Res (Phila) 2016
64
50

Methylation and miRNA effects of resveratrol on mammary tumors vs. normal tissue.
Wenyi Qin, Ke Zhang, Kaitlin Clarke, Timothy Weiland, Edward R Sauter. Nutr Cancer 2014
68
50

Recent advancements in PARP inhibitors-based targeted cancer therapy.
Ping Zhou, Justin Wang, Daniel Mishail, Cun-Yu Wang. Precis Clin Med 2020
22
50

Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma.
Olga Kondrashova, Minh Nguyen, Kristy Shield-Artin, Anna V Tinker, Nelson N H Teng, Maria I Harrell, Michael J Kuiper, Gwo-Yaw Ho, Holly Barker, Maria Jasin,[...]. Cancer Discov 2017
218
50

Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2.
Mary Grace Goll, Finn Kirpekar, Keith A Maggert, Jeffrey A Yoder, Chih-Lin Hsieh, Xiaoyu Zhang, Kent G Golic, Steven E Jacobsen, Timothy H Bestor. Science 2006
688
50

Diverse somatic mutation patterns and pathway alterations in human cancers.
Zhengyan Kan, Bijay S Jaiswal, Jeremy Stinson, Vasantharajan Janakiraman, Deepali Bhatt, Howard M Stern, Peng Yue, Peter M Haverty, Richard Bourgon, Jianbiao Zheng,[...]. Nature 2010
776
50

Retinoblastoma.
Isabelle Aerts, Livia Lumbroso-Le Rouic, Marion Gauthier-Villars, Hervé Brisse, François Doz, Laurence Desjardins. Orphanet J Rare Dis 2006
119
50

Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia.
Jianhua Yu, Yong Peng, Lai-Chu Wu, Zhiliang Xie, Youcai Deng, Tiffany Hughes, Shun He, XiaoKui Mo, Ming Chiu, Qi-En Wang,[...]. PLoS One 2013
99
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.